Nervgen Pharma Corp (NGEN.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NGEN.VN | FRX.TO | MSCL.TO | ||
| Company | Nervgen Pharma Corp | Fennec Pharmaceuticals Inc | Satellos Bioscience Inc | ||
| Price Information | |||||
| Exchange | TSX Venture | TSX | TSX | ||
| Open | 4.950 | 14.22 | 11.81 | ||
| High | 5.230 | 14.22 | 13.65 | ||
| Low | 4.930 | 14.22 | 11.81 | ||
| Latest | 5.150 | 14.22 | 13.65 | ||
| Change | +0.150 | -0.68 | +1.75 | ||
| % Change | +3.00% | -4.56% | +14.71% | ||
| Volume | 66,939 | 237 | 21,994 | ||
| 20-Day Average Volume | 49,920 | 1,196 | 44,717 | ||
| Previous Close | 5.000 | 14.90 | 11.90 | ||
| Industry | TSX Biotechnology | TSX Biotechnology | TSX Biotechnology | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 5.554 | 14.07 | 11.64 | ||
| 20-Day Raw Stochastic | 23.73% | 67.36% | 92.18% | ||
| 20-Day Relative Strength | 42.10 | 57.27 | 65.65 | ||
| Weighted Alpha | +39.45 | +11.29 | +83.59 | ||
| Today's Opinion | 8% Buy | 88% Buy | 40% Buy | ||
| Previous Opinion | 24% Buy | 88% Buy | 40% Buy | ||
| Last Month's Opinion | 40% Buy | 40% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.20% since 03/09/26 | -7.18% since 07/06/26 | +12.44% since 07/15/26 | ||
| Low | 4.870 on 03/13/26 | 14.22 on 07/17/26 | 11.39 on 07/20/26 | ||
| High | 5.700 on 03/10/26 | 15.00 on 07/13/26 | 13.65 on 07/22/26 | ||
| 1-Month | |||||
| %Chg | -10.28% since 02/13/26 | +10.66% since 06/17/26 | +70.41% since 06/22/26 | ||
| Low | 4.870 on 03/13/26 | 12.63 on 06/18/26 | 7.76 on 06/24/26 | ||
| High | 6.050 on 02/23/26 | 15.48 on 06/29/26 | 14.15 on 07/10/26 | ||
| 3-Month | |||||
| %Chg | -11.21% since 12/16/25 | +51.28% since 04/17/26 | +31.76% since 04/22/26 | ||
| Low | 4.870 on 03/13/26 | 8.45 on 04/30/26 | 7.76 on 06/24/26 | ||
| High | 8.490 on 01/08/26 | 15.48 on 06/29/26 | 14.15 on 07/10/26 | ||
| 6-Month | |||||
| %Chg | +38.07% since 09/16/25 | +35.43% since 01/15/26 | +6.31% since 01/22/26 | ||
| Low | 3.200 on 11/06/25 | 7.59 on 04/13/26 | 7.67 on 04/07/26 | ||
| High | 8.490 on 01/08/26 | 15.48 on 06/29/26 | 18.98 on 03/03/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 407,944 | 517,582 | 247,891 | ||
| Shares Outstanding, K | 79,213 | 34,737 | 20,831 | ||
| Annual Sales | 0 | 44,642,000 | 0 | ||
| Annual Net Income | -44,117,305 | -9,741,000 | -24,873,000 | ||
| Last Quarter Sales | 0 | 15,108,000 | 0 | ||
| Last Quarter Net Income | -1,675,549 | 201,000 | -9,768,000 | ||
| 60-Month Beta | 0.54 | 3.52 | 1.23 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 11/24/25 | 0.01 on 05/14/26 | -0.53 on 05/15/26 | ||
| Earnings Date | N/A | 08/13/26 | 03/26/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | N/A | N/A | N/A | ||